Trial reportJournal of neurodevelopmental disorders2026
A new effective treatment for dyslexia based on dorsal visual stream neuromodulation.
Trial report in Journal of neurodevelopmental disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Spatial extension of parafoveal processing predicts reading speed gain during reading acceleration.Journal of vision · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Developmental dyslexia (DD) affects approximately 10% of individuals, impairing reading ability thus limiting professional fulfilment and psychological wellbeing. DD is associated with both phonological and visual deficits, and the latter are attributed to dysfunctions of the magnocellular-dorsal visual stream, which has a critical role in planning saccades and supporting the extraction of letters/words identity. Currently, there are no effective treatments to restore the brain networks underlying visuospatial analysis and oculomotor efficiency. Adults with DD were enrolled in a randomised clinical trial introducing a non-invasive neuromodulation protocol specifically designed to enhance dorsal stream functionality. We used bi-focal beta-band transcranial alternating current stimulation (tACS) in parietal areas, due to the recognized role of beta oscillation in the dorsal stream functionality. Coupled with a 12-session visuoattentional training, such protocol induced improvements in reading speed, oculomotor control, and visual motion perception. Additionally, beta-tACS led to long-term enhancement of working memory. These outcomes were exclusive or superior to those obtained with a placebo/sham neuromodulation, and were accompanied by plastic changes in the stimulated brain networks. Overall, our findings show the efficacy of multisession tACS in improving core visual, oculomotor and cognitive deficits associated with reading disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.